OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer

NCT04941378 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Due to sponsor request

Conditions

Ovarian Cancer

Interventions

DRUG: OTL38
DEVICE: intraoperative imaging camera system

Sponsor

Abramson Cancer Center at Penn Medicine